Equity ownership position in Advanced Tissue Sciences by S&N more than doubles to about 8% with the conversion of a $10 mil. loan into about 2.8 mil. common stock shares. The loan was originally made in connection with a joint venture for development of Dermagraft tissue engineering technology for diabetic foot ulcers
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
